Rapid Commercialization Framework^™

The Life Science industry is under constant growing pressure to bring safe and effective drugs to market faster and cheaper. In order to effectively compete, Pharmaceutical and Biotech manufacturers must constantly innovate in their pursuit of rapid development and commercialization strategies. The competitive advantage and bottom-line benefits associated with better, more rapid development and commercialization processes are huge for these companies.

The Rapid Commercialization Framework^™ (RCF) is a collaboration between three companies, EnteGreat, GROM Consulting, and Aegis Analytical. The goal of this framework is to give Life Science companies a better set of tools to chip away at the big challenges that come with the early life cycle of new medicines and the problems associated with transitioning from clinical trials to commercial production.

RCF is based on the lessons these three companies have learned from helping dozens of Fortune 500 manufacturing companies implement programs that address different elements of this Life Science product lifecycle. We believe that companies need to take a holistic approach to achieving rapid commercialization benefits by looking at the ways in which they can better leverage their existing people, process, and technology.

The areas we have targeted to give our clients better tools for innovation are Integrated Portfolio and Project Management for clinical development stages, and Rapid Compliant Commercialization for late Clinical products that move into commercial production.

RCF includes templates for using our customers' SAP systems to better manage the projects and costing associated with new drug development. At the same time, the SAP system offers a very strong platform to support both clinical manufacturing and the planning and distribution of clinical supplies. Part of RCF addresses this in a way that not only helps companies do a better job of managing clinical manufacturing and supply chain issues during trials, but also lay a platform for quicker transition into commercial production in a scaled up compliant manufacturing environment. Last but not least, there are elements of the RCF template that help companies leverage what is learned in the manufacture of product for later stage clinical trials in ways that will speed the scale up and improve the efficiency of early commercial production for drugs that are approved, while wiping days, weeks, or possibly months off the time required to reach full commercial production rates and fill the supply chain with the newly licensed product.

If you would like to learn more about the Rapid Commercialization Framework^™, and how you can leverage it in managing aspects of your new drug life cycle, please give us a call.

Learn More:
Visit the Downloads section of our web site for educational presentations, webinars, and white papers.